Latest news

Swiss-Based Debiopharm Seeks To Boost Innovation In Japanese Cancer Research Through The New “Ideal Japan” Program

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Debiopharm reinforces the bond between Swiss and Japanese cancer research with the 2022 JCA-Mauvernay Award Ceremony

Debiopharm Encourages Breakthough Cancer Research In Japan Through its Competitive JCA Mauvernay Award

Debiopharm and the Japanese Cancer Association Announce Winners of the 2020 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Announce Winners of the 2019 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2017 JCA-Mauvernay Award